ArticleClinical epigenetics2018

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.

Wenna Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.